Brief: Guardant Health And Bayshore Healthcare Partner To Expand Access To Advanced Precision Oncology Testing In Canada
03/04/2025 13:23
April 3 (Reuters) - Guardant Health Inc GH.O: GUARDANT HEALTH AND BAYSHORE HEALTHCARE PARTNER TO EXPAND ACCESS TO ADVANCED PRECISION ONCOLOGY TESTING IN CANADA Source text: ID:nBw6pYFyHa Further company coverage: GH.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment